UNSPSC 51453008: Piperazine dihydrochloride

This classification denotes an antihelminthic agent with the molecular formula C4H10N2.2ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 17VU4Z4W88, chemically known as piperazine, dihydrochloride but more generally known as piperazine dihydrochloride, which bears US NIH Compound Identifier 8893. European Medicines Agency schedules Piperazine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14887MIG.

Most nations, for tariff and trade purposes, schedule piperazine dihydrochloride under HS 29335990. As of Q4 2014, PIPERAZINE DIHYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Piperazine dihydrochloride bears US NLM identifiers UMLS ID C0892283 and NCI Concept Code C80008. SMILES: C1CNCCN1.CL.CL.

UNSPSC 51453008 Piperazine dihydrochloride is a Commodity code for a chemical pharmaceutical ingredient, but the recent state and local opportunities tagged under it do not reflect purchase of this substance. Instead, the code shows activity in finished pharmaceutical products and medical supplies — Doxycycline Hyclate and Ciprofloxacin Hydrochloride tablets sourced through pharmaceutical warehouse arrangements, and naloxone and drug deactivation systems procured for community health and emergency response. State and local health departments, county public health systems, and community health authorities are the primary issuing bodies under this code. The mismatch between the code's nominal scope (a specific chemical intermediate) and actual buying patterns suggests either a data-entry error in the solicitation tagging or a different procurement classification scheme in use by the posting jurisdictions. Illinois Department of Public Health and Seminole County, Florida are the identified recent buyers.

Illinois Department of Public Health awarded a pharmaceutical warehouse piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC on August 28, 2026 for Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets under IFB 26-482DPH-PREPD-B-53392, with a total award of $2.99 million over 12 months plus two renewal years. Seminole County, Florida issued an IFB (60459723LAS) posted June 30, 2026 with response due July 26, 2023 (note: date discrepancy in source) for annual procurement of 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems with quarterly deliveries and an initial two-year contract term plus one-year renewal option. Geographic activity centers on Illinois and Florida, with both opportunities reflecting health-system purchasing tied to pharmaceutical supply chains or emergency medical services.